ID | 599 |
No | 599 |
Brand Name | ROTARIX |
Ingredients | LIVE ATTENUATED HUMAN ROTAVIRUS RIX4414 STRAIN NOT LESS THAN 10 6.0 CCID 50 |
Dosage Form | ORAL SUSPENSION |
Primary Packaging | TUBE |
Storage | +2'C TO +8'C |
Shelf Life | 36 MONTHS |
Pack Size | BOX OF 1 TUBE ( 1 DOSE (1.5 ML)) |
Dispensing Category | Prescription only |
ATC Classification | XX |
Pharmaceutical Class | VACCINES, ANTISERA & IMMUNOLOGICALS |
Indications | FOR THE ACTIVE IMMUNISATION OF INFANTS AGED 6-24 WEEKS FOR PREVENTION OF GASTRO-ENTERITIS DUE TO ROTAVIRUS INFECTION |
Contraindications | ROTARIC SHOULD NOT BE ADMISTERED TO SUBJECTS WITH KNOW HYPERSENSITIVITY AFTER PREVIOUS ADMINISTRATION OF ROTARIX VACCIN. |
Side Effects | THE SAFETY PROFILE PRESENTED BELOW IS BASED ON DATA FROM CLINICAL TRIALS CONDUCTED WITH EITHER THE LYOPHILISED OR THE LIQUID FOR MULATION OF ROTARIX. |
Unit Price | - |
EDL |
No |
Description | CLEAR AND COLOURLESS LIQUID |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | GLAXOSMITHKLINE BIOLOGICALS S. A |
Country | BELGIUM |
Import Registration No | EU/1/05/330/005-011 |
Import Registration Date | 1.9.2008 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-02-23 |
FDD Registration No | 02 I 3839/13 |
FDD Registration Date | 2024-04-08 |
Expiry Date | 2027-04-07 |